We are experiencing extremely high call volume related to COVID-19 vaccine interest. Please understand that our phone lines must be clear for urgent medical care needs. We are unable to accept phone calls to schedule COVID-19 vaccinations at this time. When this changes, we will update this web site. Please know that our vaccine supply is extremely small. Read all COVID-19 Vaccine Information.
Patient Care Options | Visitor Guidelines | Coronavirus Information | Self-Checker | Get Email Alerts
Enter the last name, specialty or keyword for your search below.
The goal of brain cancer research at Johns Hopkins is advancing the understanding of brain tumors and creating a fertile environment for innovation and implementation of new therapies to improve survival and quality of life for our patients.
Comprising a large range of national and international experts with multidisciplinary expertise, Johns Hopkins brain cancer laboratories are where creative and curious minds can take the risks that true innovation demands.
Our team includes:
Johns Hopkins is uniquely positioned to advance the modern science of new therapies, genomics, immunology, drug delivery systems and more. Researchers find the infrastructure and support they need to tailor scientific projects that evolve more easily into FDA-compliant clinical trials.
Our researchers are free to use all the tools essential to advancing the field, combining science and surgery, pharmacology, immunotherapy, stem cell research and gene sequencing, supported by close collaboration with Johns Hopkins’ Brain Science Institute and other centers.
No wonder Johns Hopkins is a perennial world leader in novel brain tumor treatments such as immunotherapy and direct delivery chemotherapy.
More breakthroughs are likely: New studies are finding targets for therapies to take on the most aggressive brain tumors, delving into the “skeletal” cell components of high-grade glioma and medulloblastoma. We are finding novel therapies and engineering ways to get these compounds across the blood-brain barrier.
Brain cancer research at Johns Hopkins is not just a place where scientific pioneers grow and thrive. Likewise, our Brain Tumor Center (designated by the NCI as a Comprehensive Cancer Center) is a beacon for patients with aggressive or complex tumors. At Johns Hopkins, numerous clinical trials are testing brand new treatments and experimental therapies available nowhere else.
Associate Professor of Neurosurgery
Professor of Neurosurgery
Co-Director, Trigeminal Neuralgia Center
Professor of Neurosurgery
Co-Director, Brain Cancer Program, Sidney Kimmel Cancer Center
Associate Professor of Neurosurgery
Director of Endoscopic and Minimally Invasive Neurosurgery
Professor of Oncology
Co-Director, Brain Cancer Research Program, Sidney Kimmel Cancer Center
Associate Professor of Oncology
Associate Professor of Radiation Oncology and Molecular Radiation Sciences
Vice Chair of Clinical Research
Professor of Neurology
Co-Director, Brain Cancer Program, Johns Hopkins Sidney Kimmel Comprehensive Cancer Center
Assistant Professor of Neurosurgery
Chief of Neurosurgery, Johns Hopkins Suburban Hospital
Assistant Professor of Neurosurgery
Director of Neurosurgical Oncology, Johns Hopkins Bayview Medical Center
Associate Professor of Radiation Oncology and Molecular Radiation Sciences
Professor of Neurosurgery
Irving J. Sherman Research Professor
Associate Professor of Neurosurgery
Professor of Neurosurgery
Director, Neurosurgical Operating Room
Associate Professor of Neurosurgery
Sign Up for Fundamentals
Stay up-to-date with the latest research findings from the Institute for Basic Biomedical Sciences.
Language Assistance Available:
© The Johns Hopkins University, The Johns Hopkins Hospital, and Johns Hopkins Health System. All rights reserved.
